Usefulness of CDX2 in the diagnosis of extramammary Paget disease associated with malignancies of intestinal type [9]

British Journal of Dermatology

Volumn 153, Issue 3, 2005, Pages 677-679

  De Nisi, M C ^a   D'Amuri, A ^a   Toscano, M ^a   Lalinga, A V ^a   Pirtoli, L ^a   Miracco, C ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; TRANSCRIPTION FACTOR CDX2;

ADENOCARCINOMA; ANORECTAL DISEASE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTESTINE TUMOR; LETTER; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SKIN BIOPSY; UROGENITAL TRACT TUMOR;

ADENOCARCINOMA; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL NEOPLASMS; PAGET'S DISEASE, EXTRAMAMMARY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 24344459118     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06798.x     Document Type: Letter

References (11)

1. Arnould L, Chalabreysse L, Belichard C et al. Genital carcinoma secondary to pagetoid spread from a pagetoid urothelial carcinoma. In-Situ Histopathol 1988; 32:575-7.
2. Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin, a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002; 33:549-54.
3. Lopez-Beltran A, Luque RJ, Moreno A et al. The pagetoid variant of bladder urothelial carcinoma in situ. A clinicopathological study of 11 cases. Virchows Arch 2002; 441:148-53.
4. Salamanca J, Benito A, García-Peñalver C et al. Paget's disease of the glans penis secondary to transitional cell carcinoma of the bladder: a report of two cases and review of the literature. J Cutan Pathol 2004; 31:341-5.
5. Mai KT, Alhalouly T, Landry D et al. Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease. Histopathology 2002; 41:331-6.
6. Raju RR, Goldblum JR, Hart WR. Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia. Int J Gynecol Pathol 2003; 22:127-35.
7. Battles OE, Page DL, Johnson JE. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Am J Clin Pathol 1997; 108:6-12.
8. Ohnishi T, Watanabe S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease. Br J Dermatol 2000; 142:243-7.
9. Zhang PJ, Shah M, Spiegel GW, Brooks JJ. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas. Appl Immunohistochem Mol Morph 2003; 11:306-10.
10. Li MK, Folpe AL. CDX-2, a new marker for adenocarcinoma of gastrointestinal origin. Adv Anat Pathol 2004; 11:101-5.
11. Silberg DG, Swain GP, Suh ER, Traber PG. Cdx1 and Cdx2 expression during intestinal development. Gastroenterology 2000; 119:961-71.